A CD44high/EGFRlow Subpopulation within Head and Neck Cancer Cell Lines Shows an Epithelial-Mesenchymal Transition Phenotype and Resistance to Treatment

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  La Fleur, Linnea ^a   Johansson, Ann Charlotte ^a   Roberg, Karin ^a,b  

^a LINKÖPING UNIVERSITY   (Sweden)

^b UHL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER; CETUXIMAB; CISPLATIN; DASATINIB; EPIDERMAL GROWTH FACTOR RECEPTOR; GEFITINIB; HERMES ANTIGEN; MESSENGER RNA; ANTINEOPLASTIC AGENT; EGFR PROTEIN, HUMAN; MONOCLONAL ANTIBODY; QUINAZOLINE DERIVATIVE;

ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CANCER STEM CELL; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELL SHAPE; CELL STRUCTURE; CELL SUBPOPULATION; CELL SURFACE; CHEMOSENSITIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; EPITHELIAL MESENCHYMAL TRANSITION; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; PHENOTYPIC VARIATION; PLATING MEDIUM; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RADIOSENSITIVITY; SPINDLE CELL; TUMOR GENE; UPREGULATION; ANTIBODY SPECIFICITY; CELL CYCLE; CELL LINEAGE; DNA MICROARRAY; DRUG RESISTANCE; FLOW CYTOMETRY; GAMMA RADIATION; GENE EXPRESSION; GENETICS; HEAD AND NECK TUMOR; IMMUNOLOGY; METABOLISM; RADIATION EXPOSURE; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD44; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CELL LINE, TUMOR; CELL LINEAGE; CELL PROLIFERATION; CELL SHAPE; CISPLATIN; DRUG RESISTANCE, NEOPLASM; EPITHELIAL-MESENCHYMAL TRANSITION; FLOW CYTOMETRY; GAMMA RAYS; GENE EXPRESSION; HEAD AND NECK NEOPLASMS; HUMANS; NEOPLASTIC STEM CELLS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ORGAN SPECIFICITY; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84866687783     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044071     Document Type: Article

References (41)

1. Haddad RI, Shin DM, (2008) Recent advances in head and neck cancer. N Engl J Med 359: 1143-1154.
2. Jin C, Jin Y, Wennerberg J, Akervall J, Dictor M, et al. (2002) Karyotypic heterogeneity and clonal evolution in squamous cell carcinomas of the head and neck. Cancer Genet Cytogenet 132: 85-96.
3. Wang X, Fan M, Chen X, Wang S, Alsharif MJ, et al. (2006) Intratumor genomic heterogeneity correlates with histological grade of advanced oral squamous cell carcinoma. Oral Oncol 42: 740-744.
4. Al-Hajj M, Clarke MF, (2004) Self-renewal and solid tumor stem cells. Oncogene 23: 7274-7282.
5. Fidler IJ, Kripke ML, (1977) Metastasis results from preexisting variant cells within a malignant tumor. Science 197: 893-895.
6. Heppner G, Yamashina K, Miller B, Miller F, (1986) Tumor heterogeneity in metastasis. Prog Clin Biol Res 212: 45-59.
7. Hsu DS, Lan HY, Huang CH, Tai SK, Chang SY, et al. (2010) Regulation of excision repair cross-complementation group 1 by Snail contributes to cisplatin resistance in head and neck cancer. Clin Cancer Res 16: 4561-4571.
8. Skvortsova I, Skvortsov S, Raju U, Stasyk T, Riesterer O, et al. (2010) Epithelial-to-mesenchymal transition and c-myc expression are the determinants of cetuximab-induced enhancement of squamous cell carcinoma radioresponse. Radiother Oncol 96: 108-115.
9. Prince ME, Ailles LE, (2008) Cancer stem cells in head and neck squamous cell cancer. J Clin Oncol 26: 2871-2875.
10. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ, (2005) Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 65: 10946-10951.
11. Dalerba P, Dylla SJ, Park IK, Liu R, Wang X, et al. (2007) Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci U S A 104: 10158-10163.
12. Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, et al. (2008) Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 15: 504-514.
13. Fang D, Nguyen TK, Leishear K, Finko R, Kulp AN, et al. (2005) A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res 65: 9328-9337.
14. Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, et al. (2007) Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1: 313-323.
15. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, et al. (2004) Identification of human brain tumour initiating cells. Nature 432: 396-401.
16. Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, et al. (2007) Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A 104: 973-978.
17. Locke M, Heywood M, Fawell S, Mackenzie IC, (2005) Retention of intrinsic stem cell hierarchies in carcinoma-derived cell lines. Cancer Res 65: 8944-8950.
18. Okamoto A, Chikamatsu K, Sakakura K, Hatsushika K, Takahashi G, et al. (2009) Expansion and characterization of cancer stem-like cells in squamous cell carcinoma of the head and neck. Oral Oncol 45: 633-639.
19. Le Roy H, Zuliani T, Wolowczuk I, Faivre N, Jouy N, et al. (2010) Asymmetric distribution of epidermal growth factor receptor directs the fate of normal and cancer keratinocytes in vitro. Stem Cells Dev 19: 209-220.
20. Costello RT, Mallet F, Gaugler B, Sainty D, Arnoulet C, et al. (2000) Human acute myeloid leukemia CD34+/CD38- progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities. Cancer Res 60: 4403-4411.
21. Guzman ML, Swiderski CF, Howard DS, Grimes BA, Rossi RM, et al. (2002) Preferential induction of apoptosis for primary human leukemic stem cells. Proc Natl Acad Sci U S A 99: 16220-16225.
22. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, et al. (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444: 756-760.
23. Phillips TM, McBride WH, Pajonk F, (2006) The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. J Natl Cancer Inst 98: 1777-1785.
24. Jedlinski A, Ansell A, Johansson AC, Roberg K (2012) EGFR status and EGFR ligand expression influence the treatment response of head and neck cancer cell lines. J Oral Pathol Med.
25. Roberg K, Ceder R, Farnebo L, Norberg-Spaak L, Grafstrom RC, (2008) Multiple genotypic aberrances associate to terminal differentiation-deficiency of an oral squamous cell carcinoma in serum-free culture. Differentiation 76: 868-880.
26. Leutenegger CM, Mislin CN, Sigrist B, Ehrengruber MU, Hofmann-Lehmann R, et al. (1999) Quantitative real-time PCR for the measurement of feline cytokine mRNA. Vet Immunol Immunopathol 71: 291-305.
27. Farnebo L, Jerhammar F, Vainikka L, Grenman R, Norberg-Spaak L, et al. (2008) Number of negative points: a novel method for predicting radiosensitivity in head and neck tumor cell lines. Oncol Rep 20: 453-461.
28. Biddle A, Liang X, Gammon L, Fazil B, Harper LJ, et al. (2011) Cancer stem cells in squamous cell carcinoma switch between two distinct phenotypes that are preferentially migratory or proliferative. Cancer Res 71: 5317-5326.
29. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, et al. (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133: 704-715.
30. Bao B, Wang Z, Ali S, Kong D, Banerjee S, et al. (2011) Over-expression of FoxM1 leads to epithelial-mesenchymal transition and cancer stem cell phenotype in pancreatic cancer cells. J Cell Biochem 112: 2296-2306.
31. Chen C, Wei Y, Hummel M, Hoffmann TK, Gross M, et al. (2011) Evidence for epithelial-mesenchymal transition in cancer stem cells of head and neck squamous cell carcinoma. PLoS One 6: e16466.
32. Singh A, Settleman J, (2010) EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 29: 4741-4751.
33. Arumugam T, Ramachandran V, Fournier KF, Wang H, Marquis L, et al. (2009) Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer. Cancer Res 69: 5820-5828.
34. Theys J, Jutten B, Habets R, Paesmans K, Groot AJ, et al. (2011) E-Cadherin loss associated with EMT promotes radioresistance in human tumor cells. Radiother Oncol 99: 392-397.
35. Holz C, Niehr F, Boyko M, Hristozova T, Distel L, et al. (2011) Epithelial-mesenchymal-transition induced by EGFR activation interferes with cell migration and response to irradiation and cetuximab in head and neck cancer cells. Radiother Oncol 101: 158-164.
36. Jerhammar F, Ceder R, Garvin S, Grenman R, Grafstrom RC, et al. (2011) Fibronectin 1 is a potential biomarker for radioresistance in head and neck squamous cell carcinoma. Cancer Biol Ther 10: 1244-1251.
37. Ansell A, Jerhammar F, Ceder R, Grafstrom R, Grenman R, et al. (2009) Matrix metalloproteinase-7 and-13 expression associate to cisplatin resistance in head and neck cancer cell lines. Oral Oncol 45: 866-871.
38. Shibata S, Marushima H, Asakura T, Matsuura T, Eda H, et al. (2009) Three-dimensional culture using a radial flow bioreactor induces matrix metalloprotease 7-mediated EMT-like process in tumor cells via TGFbeta1/Smad pathway. Int J Oncol 34: 1433-1448.
39. Iwai S, Yonekawa A, Harada C, Hamada M, Katagiri W, et al. (2010) Involvement of the Wnt-beta-catenin pathway in invasion and migration of oral squamous carcinoma cells. Int J Oncol 37: 1095-1103.
40. Mandal M, Myers JN, Lippman SM, Johnson FM, Williams MD, et al. (2008) Epithelial to mesenchymal transition in head and neck squamous carcinoma: association of Src activation with E-cadherin down-regulation, vimentin expression, and aggressive tumor features. Cancer 112: 2088-2100.
41. Finn RS, Dering J, Ginther C, Wilson CA, Glaspy P, et al. (2007) Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/"triple-negative" breast cancer cell lines growing in vitro. Breast Cancer Res Treat 105: 319-326.